Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MPL-Adjuvanted Hepatitis B Vaccine vs Engerix-B in Non-Responders
NCT00697931Phase 3Completed
- Sponsor
- GSK
- Start
- May 1997
- Primary completion
- Jun 1998
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised trial of hepatitis b vaccine recombinant in hepatitis B (HBV) (2 arms), sponsored by GSK. Primary endpoint: Anti-HBs antibody concentrations at Month 7. Started May 1997; status: completed.
02
Drugs
hepatitis b vaccine recombinant
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00697931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00697931.